NanoViricides
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell NanoViricides and other ETFs, options, and stocks.About NNVC
NanoViricides, Inc. is a clinical stage company, which engages in the development of nano-biopharmaceutical drugs against viruses. It focuses on anti-viral therapeutics through internal discovery and clinical development programs.
CEOAnil R. Diwan
CEOAnil R. Diwan
Employees7
Employees7
HeadquartersShelton, Connecticut
HeadquartersShelton, Connecticut
Founded2005
Founded2005
Employees7
Employees7
NNVC Key Statistics
Market cap25.88M
Market cap25.88M
Price-Earnings ratio-2.44
Price-Earnings ratio-2.44
Dividend yield—
Dividend yield—
Average volume281.16K
Average volume281.16K
High today$1.24
High today$1.24
Low today$1.18
Low today$1.18
Open price$1.20
Open price$1.20
Volume180.63K
Volume180.63K
52 Week high$2.23
52 Week high$2.23
52 Week low$0.94
52 Week low$0.94
Stock Snapshot
As of today, NanoViricides(NNVC) shares are valued at $1.20. The company's market cap stands at 25.88M, with a P/E ratio of -2.44.
On 2026-01-08, NanoViricides(NNVC) stock moved within a range of $1.18 to $1.24. With shares now at $1.20, the stock is trading +1.7% above its intraday low and -3.2% below the session's peak.
Trading activity shows a volume of 180.63K, compared to an average daily volume of 281.16K.
Over the past 52 weeks, NanoViricides(NNVC) stock has traded between a high of $2.23 and a low of $0.94.
Over the past 52 weeks, NanoViricides(NNVC) stock has traded between a high of $2.23 and a low of $0.94.
People also own
Based on the portfolios of people who own NNVC. This list is generated using Robinhood data, and it’s not a recommendation.